Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cartistem for ACL Reconstruction Healing
NCT02755376Completed
- Sponsor
- Samsung Medical Center
- Start
- Jan 2014
- Primary completion
- Apr 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Randomised trial of Cartistem in anterior cruciate ligament injury (3 arms), sponsored by Samsung Medical Center. Primary endpoint: Bone formation on interface between bone tunnel and graft at 48 weeks. Started Jan 2014; status: completed.
02
Drugs
Cartistem
03
Conditions
anterior cruciate ligament injury
Beyond the preview
Go deeper on NCT02755376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02755376.